Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.DE Filed Acc 0001193125-26-092040

Chief Operating Officer gave up 3,138 shares (to pay taxes)

  • Chief Operating Officer acquired 9,409 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Beetham Thomas W. · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Exercise or conversion : show line 1 in the form +9,409 16,409 D
2026-03-03 Shares withheld for taxes : show line 2 in the form −3,138 $29.32 $92,006 13,271 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-03-02 Grant or award : show line 3 in the form Stock Option (Right to Buy) +176,550 176,550 D
2026-03-02 Grant or award : show line 4 in the form Restricted Stock Units +35,300 35,300 D
2026-03-03 Exercise or conversion : show line 5 in the form Restricted Stock Units −9,409 28,227 D
Loading xslF345X05/ownership.xml…